Exercise and Olanzapine-samidorphan

Clinical trial NCT06740890 · RECRUITING

Trial details

NCT number: NCT06740890
Sponsor: New York State Psychiatric Institute
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophenia Disorder Schizoaffective Disorder Bipolar Disorder I or II Bipolar Disorder NOS

Start date: 2025-06-26
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.